Blackmores Limited (ASX:BKL) Shares Are On Steroids

The Blackmores Limited (ASX:BKL) share price was trading 5.70% higher today.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

The Blackmores Limited (ASX: BKL) share price was trading 5.70% higher today. Over the past month, shares of Blackmores Limited are down 6%. For comparison, the S&P/ASX 200 (INDEXASX: XJO) has climbed 1% at the same time.

About Blackmores Limited

Blackmores describes itself as Australia’s leading natural health company. Maurice Blackmore founded the company in the 1930s.

Blackmores has a number of different brands, not just the well-recognised Blackmores brand. It operates BioCeuticals, the Blackmores Institute, Fusion Health & Oriental Botanicals, Impromy, IsoWhey and Pure Animal Wellbeing (PAW).

What’s Happened?

Overnight, the US and China trade war appeared to have provided investors with some positive news (finally!). As Rask Media’s Jaz Harrison reported:

“US President Trump has announced that the United States will delay its tariff increases on Chinese goods by two weeks as a gesture of goodwill.”

Adding, “These delays came as China decided to release a list of 16 US imports that will be exempted from tariffs such as animal feed and anti-cancer medication.”

For companies — and ASX investors — who have something to lose if it’s harder to trade internationally, this is very welcome news. Heck, even if it is just a “gesture”!

Indeed, this news is probably the reason why shares of companies like Blackmores, a2 Milk Company Ltd (ASX: A2M) and even the likes of BHP Group Ltd (ASX: BHP) are trading higher today.

Buy, Hold or Sell?

I wouldn’t bet the house (or my investment dollars) on a trade resolution anytime soon.

However, I would and do make investments based on the long-term growth prospects of high-quality businesses like A2 Milk and Blackmores.

For that reason, I’ll be taking a closer look at shares of both companies in the coming months. Both companies have a foothold in China with established marketing and distribution teams. That’s more than can be said of many Australian-only focused mid-cap companies.

Having said that, we’ve identified proven ASX growth + dividend companies in our new investing report below.

[ls_content_block id=”14945″ para=”paragraphs”]

Disclosure: At the time of publishing, Owen does not have a financial interest in any of the companies mentioned.

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.